Intestinal epithelial and mucus layer surfaces

The intestinal epithelial and mucus layer surfaces represent a complex multi-component barrier that separates the host's internal environment from the luminal contents of the gastrointestinal tract. This barrier is composed of a single layer of specialized epithelial cells, including enterocytes and goblet cells, which are covered by a protective mucus blanket primarily consisting of the gel-forming mucin MUC2 (Johansson et al., 2011, Nature Reviews Gastroenterology & Hepatology). Its primary biological function is to facilitate the selective absorption of nutrients and water while simultaneously providing an immune exclusion zone that prevents the translocation of pathogens and toxins (Okumura & Takeda, 2017, Nature Reviews Immunology). Dysfunction of this surface is a hallmark of various pathologies, most notably inflammatory bowel diseases (IBD) like Crohn's disease and ulcerative colitis, where increased permeability allows for chronic immune activation (Antoni et al., 2014, World Journal of Gastroenterology). From a pharmacological perspective, these surfaces are targets for locally acting agents such as mesalamine, which reduces mucosal inflammation, and secretagogues like linaclotide that modulate epithelial ion transport (Sandborn & Hanauer, 2003, American Journal of Gastroenterology). Additionally, the mucus layer serves as a significant challenge for drug delivery, requiring specific strategies to either penetrate the gel or adhere to it for prolonged therapeutic effect (Ensign et al., 2012, Advanced Drug Delivery Reviews).

Other names

Intestinal mucosal barrierGut barrierIntestinal epitheliumMucus layerGastrointestinal barrier

Drugs targeting these surfaces typically act via local modulation of inflammatory pathways, activation of epithelial ion channels to promote fluid secretion, or by providing a physical protective coating to the mucosa (Sandborn & Hanauer, 2003, American Journal of Gastroenterology).